Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/19/2025

Emergency Blood Transfusion in Unknown Rhesus Status

Blood Selection Algorithm by Patient Category

  • The American College of Anaesthesia recommends using Group O RhD negative red blood cells for emergency transfusion when Rhesus status is unknown, with the exception that Group O RhD positive is acceptable for males, postmenopausal females, and adults without childbearing potential 1, 2, 3
  • For women of childbearing potential, always use Group O RhD negative blood to prevent RhD alloimmunization and subsequent hemolytic disease of the fetus and newborn in future pregnancies 4, 5
  • Women who are RhD negative and receive RhD positive blood can develop immune anti-D antibodies, which cause severe fetal complications 1, 2
  • For males and postmenopausal females, Group O RhD positive blood is acceptable and preferred to conserve scarce RhD negative inventory 1, 2, 4

Transition to Group-Specific Blood

  • The American College of Anaesthesia recommends switching to group-specific blood as soon as possible, typically within 10-15 minutes of laboratory receiving a properly labeled sample 1, 2, 4
  • Blood grouping can be performed in approximately 10 minutes, not including transport time 1, 2
  • Group-specific blood should be rapidly available within 15-20 minutes 4
  • In massive bleeding, patients have minimal circulating antibodies and usually accept group-specific blood without reaction 1, 2, 5

Critical Safety Considerations

  • The British Journal of Anaesthesia recommends sending blood samples to the laboratory at the earliest possible opportunity for blood grouping, antibody screening, and compatibility testing 6
  • Proper patient identification with four core identifiers is essential 7
  • Most transfusion-related morbidity results from incorrect blood administration, not blood group incompatibility 6
  • Antibodies may develop at a later stage if the patient survives, requiring follow-up antibody screening 1, 2
  • Premenopausal females whose blood group is unknown must receive O RhD negative cells to avoid sensitization 6

Practical Implementation

  • Major hemorrhage protocols should enable immediate release of blood components without prior hematologist approval 4, 5
  • Most major hemorrhage packs contain four units of RBCs and four units of FFP 4
  • Blood should be administered via wide-bore intravenous or intra-osseous access 4
  • Transfusion must be completed within 4 hours of removal from controlled storage 2, 7